BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 10, 2017
View Archived Issues
VEROnA trial explores use of vandetanib-eluting radiopaque beads for liver cancer
Read More
Iterum Therapeutics conducts phase I study of sulopenem etzadroxil
Read More
OncoArendi Therapeutics set to begin clinical studies of lead compound for asthma
Read More
Trovagene's PCM-075 granted orphan drug status in U.S.
Read More
Hyundai Pharmaceutical describes diabetes candidate HD-6277
Read More
Novel mutation in NSD1 gene found to be associated with Sotos syndrome
Read More
Compugen reports data demonstrating potential of CGEN-15032 as a target for cancer therapy
Read More
International Stem Cell develops 3-D bioprinter to treat liver diseases
Read More
Kyowa Hakko Kirin discontinues development of ARQ-197
Read More
FDA accepts for review Prolia sBLA for glucocorticoid-induced osteoporosis
Read More
sNDA submitted for rucaparib as maintenance treatment in platinum-sensitive recurrent ovarian cancer
Read More
NIA grant supports Amydis' development of ophthalmic amyloid test for CAA
Read More
Erytech resubmits Graspa MAA to EMA
Read More
Nicox and pSivida collaborate to develop sustained-release NO-donating ocular compound
Read More
Volanesorsen granted PIM designation for familial chylomicronemia syndrome
Read More
Bayer presents Pim kinase inhibitors
Read More
New integrin antagonists presented by GlaxoSmithKline
Read More
Centaurus BioPharma and collaborators divulge novel CDK inhibitors
Read More
DGMIF and Gachon University patent FGFR inhibitors
Read More
Novel Ret inhibitors presented by Blueprint Medicines
Read More
Mundipharma EDO initiates phase I/II study of tinostamustine in advanced solid tumors
Read More
RBX-2660 microbe therapy prevents recurrent Clostridium difficile infection in phase II trial
Read More